Professor | Sun Lingyun | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Sun Lingyun
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Sun Lingyun

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	1998: First in Asia to successfully use autologous bone marrow stem cell therapy for severe refractory lupus erythematosus 2007: First in the world to use allogeneic mesenchymal stem cell therapy for lupus erythematosus and other autoimmune diseases Published 505 papers, including 211 SCI papers with a cumulative impact factor of 1138 Chief of National Key R&D Program Published in journals like Cell Stem Cell, Immunity, Nat Commun, Stem Cells, Ann Rheum Dis, Nat Rev Rheumatol, Blood, Gut
Awards	2019: National Science and Technology Award, Second Prize for Invention 2013: Jiangsu Science and Technology Progress Award, First Prize 2019: Jiangsu Medical Science and Technology Award, International Science and Technology Cooperation Award 2018: Jiangsu Medical Science and Technology Award, International Science and Technology Cooperation Award 2018: Jiangsu Medical Award, Second Prize 2018: Chinese Research Hospital Association Medical Achievement Transformation Award 2016: Jiangsu Medical New Technology Introduction Award, First Prize 2014: Ministry of Education Higher Education Science and Technology Progress Award, Second Prize 2013: Chinese Medical Award, Second Prize 2013: Jiangsu Medical Award, First Prize 2013: Nanjing Science and Technology Progress Award, First Prize 2011: Jiangsu Science and Technology Progress Award, Third Prize 2009: Jiangsu Science and Technology Progress Award, Second Prize 2009: Jiangsu New Technology Introduction Special Award 2009: Nanjing Science and Technology Progress Award, First Prize 2008: Nanjing New Technology Introduction Award, First Prize

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

1998: First in Asia to successfully use autologous bone marrow stem cell therapy for severe refractory lupus erythematosus
2007: First in the world to use allogeneic mesenchymal stem cell therapy for lupus erythematosus and other autoimmune diseases
Published 505 papers, including 211 SCI papers with a cumulative impact factor of 1138
Chief of National Key R&D Program
Published in journals like Cell Stem Cell, Immunity, Nat Commun, Stem Cells, Ann Rheum Dis, Nat Rev Rheumatol, Blood, Gut

Awards

2019: National Science and Technology Award, Second Prize for Invention
2013: Jiangsu Science and Technology Progress Award, First Prize
2019: Jiangsu Medical Science and Technology Award, International Science and Technology Cooperation Award
2018: Jiangsu Medical Science and Technology Award, International Science and Technology Cooperation Award
2018: Jiangsu Medical Award, Second Prize
2018: Chinese Research Hospital Association Medical Achievement Transformation Award
2016: Jiangsu Medical New Technology Introduction Award, First Prize
2014: Ministry of Education Higher Education Science and Technology Progress Award, Second Prize
2013: Chinese Medical Award, Second Prize
2013: Jiangsu Medical Award, First Prize
2013: Nanjing Science and Technology Progress Award, First Prize
2011: Jiangsu Science and Technology Progress Award, Third Prize
2009: Jiangsu Science and Technology Progress Award, Second Prize
2009: Jiangsu New Technology Introduction Special Award
2009: Nanjing Science and Technology Progress Award, First Prize
2008: Nanjing New Technology Introduction Award, First Prize

Areas of Focus	Pathogenesis of Systemic Lupus Erythematosus Mesenchymal Stem Cell Therapy for Autoimmune Diseases
Publications	Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis, Not mentioned, 2017 Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis, Not mentioned, 2019 Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: A long-term retrospective study, Not mentioned, 2018 Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis, Not mentioned, 2020 Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells, Not mentioned, 2018 Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9, Not mentioned, 2018 Response to: 'Correspondence on 'Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the Global Burden of Disease study 2017' by Chiang et al., Not mentioned, 2020 Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients, Not mentioned, 2019

Areas of Focus

Pathogenesis of Systemic Lupus Erythematosus
Mesenchymal Stem Cell Therapy for Autoimmune Diseases

Publications

Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis, Not mentioned, 2017
Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis, Not mentioned, 2019
Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: A long-term retrospective study, Not mentioned, 2018
Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis, Not mentioned, 2020
Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells, Not mentioned, 2018
Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9, Not mentioned, 2018
Response to: 'Correspondence on 'Incidence trend of five common musculoskeletal disorders from 1990 to 2017 at the global, regional and national level: results from the Global Burden of Disease study 2017' by Chiang et al., Not mentioned, 2020
Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients, Not mentioned, 2019

Systemic Lupus Erythematosus Pathogenesis Autoimmune Diseases Mesenchymal Stem Cells Therapy Clinical Application Research Stem Cell Transplantation Immunology Inflammation

Song Han - Wuhan University

Shijun He - University of Chinese Academy of Sciences

Lingyun Long - University of Chinese Academy of Sciences

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us